IVZ vs MET: fair value comparison
Invesco Ltd. and MetLife, Inc. · Updated 2026-09-12
Both currently screen as fairly valued on TickrTrends' Forward Fair Value model. Within Financial Services, MET currently sits closer to the top of our discount ranking. IVZ carries the stronger quality grade.
| IVZ | MET | |
|---|---|---|
| Verdict | Fairly valued | Fairly valued |
| Last price | $32.28 | $97.14 |
| 12-month range | $23.37–$31.99 | $71.17–$96.13 |
| Sector rank | #80 of 165 Financial Services | #79 of 165 Financial Services |
| Quality grade | B | C |
| Leverage | Low | Moderate |
| Margin trend | Expanding | Contracting |
| Revenue growth | Modest | Modest |
| RSI zone | Neutral | Neutral |
| 52-week position | The top quarter | The top quarter |
Full single-stock breakdowns: IVZ fair value analysis · MET fair value analysis